JP5611216B2 - 眼疾患の予防又は治療用組成物 - Google Patents

眼疾患の予防又は治療用組成物 Download PDF

Info

Publication number
JP5611216B2
JP5611216B2 JP2011533097A JP2011533097A JP5611216B2 JP 5611216 B2 JP5611216 B2 JP 5611216B2 JP 2011533097 A JP2011533097 A JP 2011533097A JP 2011533097 A JP2011533097 A JP 2011533097A JP 5611216 B2 JP5611216 B2 JP 5611216B2
Authority
JP
Japan
Prior art keywords
eye
present
general formula
composition
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011533097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012505928A5 (enExample
JP2012505928A (ja
Inventor
ウ カン・スン
ウ カン・スン
ホ キム・チョル
ホ キム・チョル
ジョ キム・ソク
ジョ キム・ソク
Original Assignee
ベネバイオシス カンパニー リミテッド
ベネバイオシス カンパニー リミテッド
スンキュンクワン ユニヴァーシティー ファウンデーション フォー コーポレイト コラボレイション
スンキュンクワン ユニヴァーシティー ファウンデーション フォー コーポレイト コラボレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベネバイオシス カンパニー リミテッド, ベネバイオシス カンパニー リミテッド, スンキュンクワン ユニヴァーシティー ファウンデーション フォー コーポレイト コラボレイション, スンキュンクワン ユニヴァーシティー ファウンデーション フォー コーポレイト コラボレイション filed Critical ベネバイオシス カンパニー リミテッド
Publication of JP2012505928A publication Critical patent/JP2012505928A/ja
Publication of JP2012505928A5 publication Critical patent/JP2012505928A5/ja
Application granted granted Critical
Publication of JP5611216B2 publication Critical patent/JP5611216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/20—Organic compounds containing oxygen
    • C11D3/22—Carbohydrates or derivatives thereof
    • C11D3/221—Mono, di- or trisaccharides or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/20—Organic compounds containing oxygen
    • C11D3/22—Carbohydrates or derivatives thereof
    • C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • C11D3/227—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin with nitrogen-containing groups
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
JP2011533097A 2008-10-20 2009-10-16 眼疾患の予防又は治療用組成物 Active JP5611216B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020080102660A KR101116868B1 (ko) 2008-10-20 2008-10-20 안질환의 예방 또는 치료용 조성물
KR10-2008-0102660 2008-10-20
PCT/KR2009/005983 WO2010047500A2 (ko) 2008-10-20 2009-10-16 안질환의 예방 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2012505928A JP2012505928A (ja) 2012-03-08
JP2012505928A5 JP2012505928A5 (enExample) 2012-12-06
JP5611216B2 true JP5611216B2 (ja) 2014-10-22

Family

ID=42119814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533097A Active JP5611216B2 (ja) 2008-10-20 2009-10-16 眼疾患の予防又は治療用組成物

Country Status (7)

Country Link
US (1) US8524686B2 (enExample)
EP (1) EP2361627B1 (enExample)
JP (1) JP5611216B2 (enExample)
KR (1) KR101116868B1 (enExample)
DK (1) DK2361627T3 (enExample)
ES (1) ES2472440T3 (enExample)
WO (1) WO2010047500A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
US10330670B2 (en) 2012-10-24 2019-06-25 National University Corporation Tokyo University Of Agriculture And Technology Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
WO2018171850A1 (en) * 2017-03-23 2018-09-27 Københavns Universitet Prebiotic compounds or compositions for use in treatment of sjögren's syndrome
KR102495473B1 (ko) 2020-10-06 2023-02-06 서울대학교병원 앰피레귤린을 유효성분으로 포함하는 안질환 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
IT1271624B (it) * 1994-03-21 1997-06-04 Lifegroup Spa Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'
JP4082746B2 (ja) * 1995-03-20 2008-04-30 雪印乳業株式会社 シアリルラクトースの分離方法
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
AU7277798A (en) * 1997-05-01 1998-11-24 Cytel Corporation Use of sialyl galactosides and related compounds as anti-angiogenic agents
US6239088B1 (en) * 1999-03-19 2001-05-29 Color Access, Inc. Nonirritating cleansing composition
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20070286896A1 (en) * 2003-08-01 2007-12-13 National Institute Of Advanced Industrial Science And Technology Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome
CA2548140A1 (en) * 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
WO2007047489A2 (en) * 2005-10-18 2007-04-26 Acadia Pharmaceuticals Inc. Compositions and methods for use in cancer therapy

Also Published As

Publication number Publication date
WO2010047500A3 (ko) 2010-08-19
KR101116868B1 (ko) 2012-02-29
JP2012505928A (ja) 2012-03-08
EP2361627B1 (en) 2014-03-12
KR20100043570A (ko) 2010-04-29
WO2010047500A2 (ko) 2010-04-29
DK2361627T3 (da) 2014-06-23
EP2361627A2 (en) 2011-08-31
ES2472440T3 (es) 2014-07-01
US20110237543A1 (en) 2011-09-29
US8524686B2 (en) 2013-09-03
EP2361627A4 (en) 2012-05-02

Similar Documents

Publication Publication Date Title
KR102584063B1 (ko) 부분불소화 화합물
JP3795105B2 (ja) 人工涙として使用するための眼用製剤
KR100776124B1 (ko) 안과용 의약 조성물
KR101438744B1 (ko) 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP2016065089A (ja) 眼および付属器組織の炎症を処置するための治療組成物
JP5611216B2 (ja) 眼疾患の予防又は治療用組成物
JP5616620B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP7526718B2 (ja) ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物
KR101023401B1 (ko) 콘택트 렌즈용 액제 및 이것을 사용한 콘택트 렌즈의 친수화 처리 방법
JP2011116686A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP5616617B2 (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤
EP2349232A1 (en) Ophthalmic compositions useful for improving visual acuity
WO2013012692A1 (en) Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof
WO2011111084A1 (en) Pharmaceutical composition based on glycyrrhizin and eg56 polymer for the preparation of anti-inflammatory products
WO2017043612A1 (ja) ドライアイ改善剤
Alberto Chiaradia et al. Hot topics in dry eye disease
KR20160060227A (ko) 안과 질환 예방 또는 치료용 조성물
RU2302231C1 (ru) Глазные капли для лечения синдрома сухого глаза
Chang et al. Efficacy of cordyceps cicadae (Ascomycota) mycelium supplementation for amelioration of dry eye symptoms: A Randomized, Double-Blind clinical pilot study
EP3150211B1 (en) Therapeutic agent for keratoconjunctive disorder
JP2023528633A (ja) ドライアイ症候群の治療のためのマイクロエマルション
KR101932862B1 (ko) 안구건조증 예방 및 치료용 조성물
KR100845942B1 (ko) 부작용이 경감된 점안용 조성물과 그의 제조 방법
JPWO2020138135A1 (ja) 眼科用組成物
US20240189254A1 (en) Xylitol Topical Ocular Solution

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121016

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121016

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140306

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140313

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140403

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140410

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140507

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140606

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140902

R150 Certificate of patent or registration of utility model

Ref document number: 5611216

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250